Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TW1Q
|
||||
Former ID |
DIB004408
|
||||
Drug Name |
DP-3005
|
||||
Synonyms |
TCCB (hypertension/angina), Diakron Pharmaceuticals; T-type calcium channel blocker (hypertension/angina), Diakron Pharmaceuticals
|
||||
Indication | Angina pectoris [ICD9: 413; ICD10:I20] | Investigative | [1] | ||
Company |
Diakron Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Voltage-dependent T-type calcium channel subunit alpha-1H | Target Info | Blocker | [1] | |
KEGG Pathway | MAPK signaling pathway | ||||
Calcium signaling pathway | |||||
Circadian entrainment | |||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | NCAM1 interactions | ||||
WikiPathways | Corticotropin-releasing hormone | ||||
NCAM signaling for neurite out-growth | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 536). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.